What are the latest guidelines for managing Hypertension (High Blood Pressure)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The latest hypertension guidelines recommend initiating treatment when blood pressure (BP) consistently exceeds 130/80 mmHg, with a target of below this threshold for most adults, as stated in the 2022 World Health Organization guideline executive summary 1.

Key Recommendations

  • First-line medications include thiazide diuretics, calcium channel blockers, ACE inhibitors, or ARBs, with specific dosages such as chlorthalidone 12.5-25mg daily or hydrochlorothiazide 12.5-50mg daily, amlodipine 2.5-10mg daily, lisinopril 10-40mg daily, or losartan 25-100mg daily.
  • For Black patients, initial therapy should favor thiazide diuretics or calcium channel blockers, as recommended by the 2017 American College of Cardiology/American Heart Association guideline 1.
  • Most patients will require two or more medications to achieve target BP, and fixed-dose combination pills improve adherence.
  • Lifestyle modifications are essential for all patients, including:
    • Sodium restriction (<2300mg/day)
    • Regular physical activity (150 minutes/week)
    • Weight management
    • Limited alcohol consumption
    • The DASH diet

Monitoring and Treatment Intensification

  • BP should be monitored regularly, ideally with home measurements to avoid white-coat hypertension.
  • Treatment should be intensified if targets aren't met within 3-6 months.
  • For patients over 65, a slightly higher target of <140/90 mmHg may be appropriate, as suggested by the 2022 World Health Organization guideline executive summary 1.

Individualized Treatment Decisions

  • Treatment decisions should be individualized based on comorbidities, medication tolerability, and patient preferences, taking into account the latest evidence from the 2022 World Health Organization guideline executive summary 1 and the 2017 American College of Cardiology/American Heart Association guideline 1.

From the Research

Diagnosis and Definition of Hypertension

  • Hypertension is defined as persistent systolic blood pressure (SBP) at least 130 mm Hg or diastolic BP (DBP) at least 80 mm Hg 2
  • It can also be defined as persistently elevated systolic blood pressure (SBP) >140 mmHg and/or diastolic blood pressure (DBP) at least 90 mmHg 3

Lifestyle Modifications for Hypertension

  • First-line therapy for hypertension is lifestyle modification, including weight loss, healthy dietary pattern that includes low sodium and high potassium intake, physical activity, and moderation or elimination of alcohol consumption 2
  • Lifestyle changes should be continued even when blood pressure-lowering medications are prescribed 3
  • Specific recommendations include maintaining a healthy body weight, increased levels of different types of physical activity, healthy eating and drinking, avoidance and cessation of smoking and alcohol use, management of stress and sleep levels 3
  • Lifestyle interventions such as regular physical exercise, body weight management, and healthy dietary patterns can help prevent and treat hypertension 4

Dietary Approaches to Stop Hypertension (DASH) Diet

  • The DASH diet is a potentially effective treatment for pre-hypertensive and hypertensive patients 5
  • The modified DASH diet can reduce mean systolic and diastolic BP, waist circumference, and triglyceride concentration in hypertension patients 5
  • The DASH diet can also be prescribed for many other chronic conditions and can help control metabolic risk factors such as body weight, BMI, and blood pressure 6

Pharmacologic Therapy for Hypertension

  • First-line drug therapy for hypertension consists of a thiazide or thiazidelike diuretic, an angiotensin-converting enzyme inhibitor or angiotensin receptor blocker, and a calcium channel blocker 2
  • The decision to initiate antihypertensive medication should be based on the level of BP and the presence of high atherosclerotic CVD risk 2
  • Randomized clinical trials have established the efficacy of BP lowering to reduce the risk of CVD morbidity and mortality 2

Blood Pressure Targets

  • The target blood pressure is <130/80 mm Hg for adults <65 years and SBP <130 mm Hg in adults ≥65 years 2
  • Achieving these targets can help reduce the risk of cardiovascular disease events and death 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.